Safety, Tolerability, and Pharmacokinetics of CSX-1004

NCT06005402 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid Overdose
Opioid Use Disorder

Interventions

BIOLOGICAL: CSX-1004
BIOLOGICAL: Placebo

Sponsor

Cessation Therapeutics, Inc.

Collaborators

[object Object]